Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Virginia Bluthgen"'
Autor:
Isabelle Rouquette, Estelle Taranchon-Clermont, Julia Gilhodes, Maria-Virginia Bluthgen, Romain Perallon, Lara Chalabreysse, Anne De Muret, Veronique Hofman, Alexander Marx, Marie Parrens, Veronique Secq, Vincent Thomas de Montpreville, Françoise Galateau-Salle, Pierre Brousset, Julie Milia, Nicolas Girard, Benjamin Besse, Thierry Jo Molina, Julien Mazières
Publikováno v:
Biomarker Research, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Background Immunotherapy is currently under investigation in B3 Thymoma (TB3) and Thymic Carcinoma (TC). PD-L1 expression has been evaluated on a limited number of patients with selected antibodies. We aimed to analyze cohort of TB3 and TC w
Externí odkaz:
https://doaj.org/article/2146e8849ab54a3a9f789f3cef96aa72
Publikováno v:
European Respiratory Review, Vol 24, Iss 138, Pp 582-593 (2015)
In advanced nonsmall cell lung cancer (NSCLC) patients, platinum-based combination chemotherapy is standard treatment in the first-line setting; however, the large majority of patients ultimately progress. For more than a decade, single-agent therapy
Externí odkaz:
https://doaj.org/article/32a51e094084499ba43bc82be333572a
Autor:
Martina Spotti, José N. Minatta, Manglio M. Rizzo, Nicolás Castagneris, Susana Sena, Gonzalo Recondo, María Virginia Bluthgen
Publikováno v:
Oncología Clínica. 27
La secuenciación de nueva generación (NGS) ha revolucionado el diagnóstico molecular del cáncer de pulmón. A pesar que el tejido tumoral ha sido históricamente el bioespecimen estándar, éste tiene algunas limitaciones. La biopsia lí
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5727bcb35b3467cec8ed9f7508247dc4
https://doi.org/10.56969/oc.v27i2.79
https://doi.org/10.56969/oc.v27i2.79
Autor:
Mariona Riudavets, Edouard Auclin, Miguel Mosteiro, Naomi Dempsey, Margarita Majem, Arsela Prelaj, Rafael López-Castro, Joaquim Bosch-Barrera, Sara Pilotto, Elena Escalera, Marco Tagliamento, Joaquin Mosquera, Gerard Zalcman, Frank Aboubakar Nana, Santiago Ponce, Alessandro Dal Maso, Martina Spotti, Xavier Mielgo-Rubio, Elodie Mussat, Roxana Reyes, Jose-Carlos Benítez, Lorena Lupinacci, Boris Duchemann, Andrea De Giglio, Juan Bautista Blaquier, Clarisse Audigier-Valette, Matthias Scheffler, Ernest Nadal, Gilberto de Lima Lopes, Diego Signorelli, Rosario Garcia-Campelo, Jessica Menis, Virginia Bluthgen, Marc Campayo, Gonzalo Recondo, Benjamin Besse, Laura Mezquita, David Planchard
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a3021508040d7259865b84d344c37b3
https://doi.org/10.2139/ssrn.4245514
https://doi.org/10.2139/ssrn.4245514
Autor:
Virginia Bluthgen, Morgane Masson, Mathieu Rouanne, Julie Massé, Frank Aboubakar, Ithar Gataa, Myriam Kossai, Edouard Auclin, Laura Mezquita, Lizza E.L. Hendriks, David Planchard, Caroline Caramella, Pierre Alemany, Jean-Pierre Pignon, Anas Gazzah, Nina Radosevic-Robin, Sylvestre Le Moulec, Benjamin Besse, Julien Adam, Caroline Rossoni
Publikováno v:
European Journal of Cancer, 145, 221-229. ELSEVIER SCI LTD
Background: The established role of morphological evaluation of tumour-infiltrating lymphocytes (TILs) with immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC) is unknown. We aimed to determine TIL association with the outcome f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45a672bbab27fa4aa7f4e6cd40e82f7
https://cris.maastrichtuniversity.nl/en/publications/dfb923fb-1680-4ede-8b15-dc723958492e
https://cris.maastrichtuniversity.nl/en/publications/dfb923fb-1680-4ede-8b15-dc723958492e
Autor:
Gonzalo Recondo, Matías Cerini, Victoria Faura, Maria Virginia Bluthgen, Aldo Perfetti, Martin Naveira, Carlos Silva, L. Lupinacci, Nicolás Minatta, Florencia Rizzi, Alejandro Kuzminin, Manglio Miguel Rizzo, Alejandro J. Videla
Publikováno v:
International journal of clinical oncology. 26(6)
Immune-checkpoint inhibitors (ICIs) are standard treatments for metastatic non-small cell lung cancer (NSCLC). Patients with poor performance status (PS) are underrepresented in clinical trials. We evaluate the efficacy and safety of ICIs in a real-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26e74d49d80f27b90acee1144227ea5
https://pubmed.ncbi.nlm.nih.gov/33715058
https://pubmed.ncbi.nlm.nih.gov/33715058
Autor:
Anas Gazzah, David Planchard, Lambros Tselikas, Nathalie Lassau, Etienne Rouleau, Melodie Tazdait, Alison Dormieux, Caroline Caramella, Cécile Le Péchoux, Jordi Remon, Laura Mezquita, Paul Henry Cournede, Francesco Facchinetti, Frank Aboubakar, Ludovic Lacroix, Charles Naltet, Corinne Balleyguier, Julien Adam, Maria-Virginia Bluthgen, Pernelle Lavaud, Benjamin Besse
Publikováno v:
European Radiology
European Radiology, Springer Verlag, 2020, 30 (9), pp.5021-5028. ⟨10.1007/s00330-020-06784-y⟩
European radiology, Vol. 30, no. 9, p. 5021-5028 (2020)
European Radiology, Springer Verlag, 2020, 30 (9), pp.5021-5028. ⟨10.1007/s00330-020-06784-y⟩
European radiology, Vol. 30, no. 9, p. 5021-5028 (2020)
OBJECTIVES: The aim of our study was to investigate the association between driver oncogene alterations and metastatic patterns on imaging assessment, in a large cohort of metastatic lung adenocarcinoma patients. METHODS: From January 2010 to May 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691eccb1b635be7a7f8caeff921dd193
https://hal-centralesupelec.archives-ouvertes.fr/hal-03127555
https://hal-centralesupelec.archives-ouvertes.fr/hal-03127555
Publikováno v:
Future oncology (London, England). 16(23)
Immune checkpoint inhibitors directed against CTLA-4, PD-1 and PD-L1 have transformed the treatment of patients with cancer. Immunotherapy regimens have evolved from a single agent approach to the combination of immune checkpoint inhibitors like anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e213302075395410516ff4c8af7be590
https://pubmed.ncbi.nlm.nih.gov/32501724
https://pubmed.ncbi.nlm.nih.gov/32501724
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.